Law ❯ Regulatory Affairs

FDA Regulations

Drug Approval Process Drug Approval Risk Evaluation and Mitigation Strategy Abortion Drugs

DOJ Asks Texas Court to Pause Texas–Florida Mifepristone Suit During FDA Review

The move reflects a broader strategy to route state challenges through an ongoing FDA safety review rather than courtroom rulings.

GOP Senators Move to Curb Mifepristone After FDA Clears Second Generic

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions